RESULTS and PUBLICATIONS


Publications

2011

Basso E (2011) Poster presentation: V Instituto de Medicina Molecular PhD student meeting Lisbon, Portugal.

Basso E (2011) Poster presentation: XII Meeting of the Portoguese Neuroscience Society Lisbon, Portugal.

Basso E (2011) Poster presentation: ISN Satellite meeting on synucleinopathies Naxos, Greece.

Buck K, Landeck N, Ulusoy A, Kirik D (2011) Polo-kinase 2 and 3 phosphorylate alpha-synuclein at Ser129 in vivo. Poster presentation: Society for Neuroscience Washington, DC.

Ciaccioli G, Martins A, Calado P, Vieira H (2011) ASyn and tau: new drug tagert for neurodegenerative diseases. Poster presentation: ISN Satellite meeting on synucleinopathies Naxos, Greece.

Landeck N, Buck K, Kirik D (2011) Characterization of alpha-synuclein and D70-83 alpha-synuclein expressing AAV vectors as controls for alpha-synuclein expression in vivo. Poster presentation: Society for Neuroscience Washington, DC.

Nouri F (2011) Detection of alpha-Synuclein in human plasma and its interaction with different apolipoproteins. Poster presentation: ISN Satellite meeting on synucleinopathies Naxos, Greece.

Nouri F (2011) The effect of different apoporteinE isoforms (ApoE2, 3 and 4) in different concentrations on recombinant alpha-syn aggregation. Poster presentation: Marie Curie Symposium Warsaw, Poland.

Nouri F (2011) The effect of different apoproteinE isoforms (ApoE2, 3 and 4) in different concentrations on recombinant alpha-syn aggregation. Poster presentation: Annual Poster Session of Lancaster University Lancaster, UK.

Nouri F (2011) The investigation of the excretion of alpha-synuclein into plasma. Poster presentation: Annual Poster Session of Lancaster University Lancaster, UK.

Xilouri M, Brekk OR, Peng HY, Papasilekas T, Vekrellis K, Stefanis L (2011) Targeting the CMA pathway in neuronal cells mitigates alpha-synuclein induced toxicity. Poster presentation: ISN satellite meeting on synucleinopathies Naxos, Greece.

2012

Basso E (2012) Poster presentation: IV Instituto de Medicina Molecular PhD student meeting Lisbon, Portugal.

Brekk OR, Xilouri M, Pitychoutis PM, Kirik D, Stefanis L (2012) Targeting chaperone-mediated autophagy by lamp2a over-expression as a method of counteracting alpha-synuclein-induced toxicity. Poster presentation: 8th FENS Forum Barcelona, Spain.

Buck K, Landeck N, Ulusoy A, Kirik D (2012) Effects of increased levels of endogenous rat P(S129) alpha-synuclein in nigral dopaminergic neurons. Poster presentation: Society for Neuroscience New Orleans, LA.

Ciaccioli G, Martins A, Rodrigues C, Vieira H, Calado P (2012) alpha-Synuclein and tau interaction: new drug target for neurodegenerative diseases. Poster presentation: 8th FENS Forum Barcelona, Spain.

Rannikko EH, Vesterager LB, Shaik JH, Weber SS, Cornejo Castro EM, Fog K, Jensen PH, Kahle PJ (2012) Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion. Journal of neurochemistry.

Xilouri M, Peng HY, Stefanis L (2012) Chaperone mediated autophagy (CMA) in neurons.  In: Autophagy of the Nervous System(Chu, C. and Yue, Z., eds): World Scientific.

Xilouri M BO, Landeck N Pityhoutis PM, Papailekas T, Papadopoulou-Daifoti Z, Vekrellis K, Kirik D, Stefanis L (2012) Boosting Chaperone-Mediated Autophagy as a means to mitigate alpha-synuclein-mediated neurotoxicity. . Poster presentation: Hellenic Society of Neuroscience Meeting, Athens, Greece.

2013

Basso E, Antas P, Marijanovic Z, Goncalves S, Tenreiro S, Outeiro TF (2013) PLK2 Modulates alpha-Synuclein Aggregation in Yeast and Mammalian Cells. Molecular neurobiology.

Ciaccioli G, Martins A, Rodrigues C, Abrantes M, Vieira H, Calado P (2013) A Powerful Yest Model to Investigate the Synergistic Interaction of alpha-Synuclein and Tau in Neurodegeneration. Poster presentation: SPN Luso, Portugal.

Ciaccioli G, Martins A, Rodrigues C, Vieira H, Calado P (2013) A powerful yeast model to investigate the synergistic interaction of alpha-synuclein and tau in neurodegeneration. PloS one 8:e55848.

Ouberai MM, Wang J, Swann MJ, Galvagnion C, Guilliams T, Dobson CM, Welland ME (2013) alpha-synuclein senses lipid packing defects and induces lateral expansion of lipids leading to membrane remodeling. The Journal of biological chemistry.

Skora L, Fonseca-Ornelas L, Hofele RV, Riedel D, Giller K, Watzlawik J, Schulz-Schaeffer WJ, Urlaub H, Becker S, Zweckstetter M (2013) Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants. The Journal of biological chemistry 288:2994-3002.

Xilouri M, Brekk OR, Kirik D, Stefanis L (2013) LAMP2A as a therapeutic target in Parkinson disease. Autophagy 9.

Xilouri M, Brekk OR, Landeck N, Pitychoutis PM, Papasilekas T, Papadopoulou-Daifoti Z, Kirik D, Stefanis L (2013) Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration. Brain : a journal of neurology 136:2130-2146.

Xilouri M, Brekk OR, Stefanis L (2013) Alpha-synuclein and protein degradation systems: a reciprocal relationship. Molecular neurobiology 47:537-551.


Outreach Activity